Literature DB >> 30976829

[The CIMH track concept in the treatment of psychotic disorders].

Dusan Hirjak1, Peter Gass2, Michael Deuschle2, F Markus Leweke2,3, Andreas Böhringer2, Nadine Schenkel4, Doris Borgwedel4, Marco Heser4, Antje Breisacher4, Andreas Meyer-Lindenberg2.   

Abstract

The treatment of psychotic disorders and illnesses is a challenge for therapists and institutions due to the heterogeneity of the cause and course, refractory symptoms, lack of therapy adherence and high rates of relapse. These circumstances can be effectively counteracted by the flexibility of therapeutic approaches and settings. A useful but rarely used concept is the treatment of psychoses within the so-called track unit. A track unit is defined as a syndrome-oriented, decentralized, modular unit, adjusted to the patient's individual stage-specific needs across both inpatient and outpatient sectors. The track concept offers a fully integrated sector-spanning model of treatment at all stages of psychotic illnesses as well as a continuity of treatment. Another important goal is the early availability of timely treatment for as many psychotic patients as possible so that the symptoms can be alleviated as soon as possible and the quality of life can be sustainably improved or preserved. The track concept not only improves the current situation of treatment for acutely or chronically psychotic patients but also represents a necessary investment in the future. This treatment model aims to ensure that the good but complex and costly treatment options are available to patients even if inpatient treatment is not favored by the patient.

Entities:  

Keywords:  CIMH; Central Institute of Mental Health; Psychosis; Track-concept; Track-unit

Mesh:

Year:  2020        PMID: 30976829     DOI: 10.1007/s00115-019-0711-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  38 in total

1.  Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia.

Authors:  S Klingberg; A Wittorf; A Fischer; K Jakob-Deters; G Buchkremer; G Wiedemann
Journal:  Acta Psychiatr Scand       Date:  2009-11-05       Impact factor: 6.392

2.  [Psychiatric Intensive Care Units--Contra].

Authors:  G Juckel
Journal:  Psychiatr Prax       Date:  2015-06-23

Review 3.  A systematic review and meta-analysis of recovery in schizophrenia.

Authors:  Erika Jääskeläinen; Pauliina Juola; Noora Hirvonen; John J McGrath; Sukanta Saha; Matti Isohanni; Juha Veijola; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

4.  Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study.

Authors:  Stefan Klingberg; Wolfgang Wölwer; Corinna Engel; Andreas Wittorf; Jutta Herrlich; Christoph Meisner; Gerhard Buchkremer; Georg Wiedemann
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

5.  The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study.

Authors:  Peter Falkai; Berend Malchow; Thomas Wobrock; Oliver Gruber; Andrea Schmitt; William G Honer; Frank-Gerald Pajonk; Frank Sun; Tyrone D Cannon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-11-17       Impact factor: 5.270

6.  Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

Authors:  Glenn E Hunt; Jenny Bergen; Marie Bashir
Journal:  Schizophr Res       Date:  2002-04-01       Impact factor: 4.939

7.  Time course and biologic correlates of treatment response in first-episode schizophrenia.

Authors:  J Lieberman; D Jody; S Geisler; J Alvir; A Loebel; S Szymanski; M Woerner; M Borenstein
Journal:  Arch Gen Psychiatry       Date:  1993-05

8.  [Guideline-conform psychiatric psychotherapeutic treatment for patients with schizophrenia : A normative evaluation of necessary personnel requirements].

Authors:  S Mehl; P Falkai; M Berger; M Löhr; D Rujescu; J Wolff; T Kircher
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

Review 9.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

Review 10.  Substance abuse in patients with schizophrenia.

Authors:  Bernadette Winklbaur; Nina Ebner; Gabriele Sachs; Kenneth Thau; Gabriele Fischer
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

View more
  3 in total

Review 1.  [Digital forms of service delivery for personalized crisis resolution and home treatment].

Authors:  Christian Rauschenberg; Dusan Hirjak; Thomas Ganslandt; Julia C C Schulte-Strathaus; Anita Schick; Andreas Meyer-Lindenberg; Ulrich Reininghaus
Journal:  Nervenarzt       Date:  2021-03-17       Impact factor: 1.214

Review 2.  [Differential diagnostic distinction between substance-induced and primary psychoses: : Recommendations for general psychiatric and forensic practice].

Authors:  Dusan Hirjak; Andreas Meyer-Lindenberg; Geva A Brandt; Harald Dreßing
Journal:  Nervenarzt       Date:  2021-03-03       Impact factor: 1.214

Review 3.  [Cross-sectoral therapeutic concepts and innovative technologies: new opportunities for the treatment of patients with mental disorders].

Authors:  Dusan Hirjak; Ulrich Reininghaus; Urs Braun; Markus Sack; Heike Tost; Andreas Meyer-Lindenberg
Journal:  Nervenarzt       Date:  2021-03-05       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.